Table 2.
Selected combination studies with BCR inhibitors
Selected combination studies with BCR inhibitors

TBD indicates to be determined; CLL, chronic lymphocytic leukemia; and NHL, non-Hodgkin lymphoma.

*NCT codes indicate ongoing studies with data available at www.clinicaltrials.gov.

or Create an Account

Close Modal
Close Modal